In conclusion, the present study has shown that a high level of p53 protein in cPNETs measured by immunostaining intensity was associated with poor patient survival, supporting the findings of a previous study, and appeared to reflect the aggressiveness of the tumours. This evidence concerns the gene TP53 and neoplasm.